This suggests that p16INK4a and p14ARF are promising biomarkers for the diagnosis of CCA, but issues of reduced sensitivity, such as the combination of additional biomarkers for diagnosis, must be addressed. This evidence concerns the gene CDKN2A and cholangiocarcinoma.